Dr. Reddy’s Laboratories deploys Salesforce CRM

Published: 23rd February 2011
Views: N/A

Salesforce, the enterprise cloud computing company, today announced that pharmaceutical company, Dr. Reddy’s Laboratories, has deployed its CRM across 200 users within 60 days.

The company informed that it has decided to move its active pharmaceutical ingredients (API) marketing business to the cloud in order to improve visibility into its deals pipeline, track its end-to-end sales cycle and better analyze its sales funnel.

Salesforce’s ability to seamlessly integrate data captured offline with online systems, is of immense help to our field sales team who need to track and update customer data on regular basis Salesforce is the enterprise cloud computing company. Based on Salesforce real-time, multitenant architecture, the company’s platform and CRM applications have revolutionized the way companies collaborate and communicate with their customers, including:

• The Sales Cloud, for sales force automation and contact management

• The Service Cloud, for customer service and support solutions

• The Jigsaw Data Cloud, for ensuring data integrity and quality

• Salesforce Chatter, for social collaboration

• The Force platform, for custom application development

• Database, the world’s first enterprise cloud database

• The App Exchange, the world’s leading marketplace for enterprise cloud computing applications.

Dr. Reddy’s implemented Salesforce CRM with the help of Business Intelligence Sloutions firm Bodhtree, who used its data integration engine Midas to integrate with existing mail, calendar, and SAP systems. By streamlining its sales business on Salesforce, Dr. Reddy’s expects to increase revenue by more than 30 percent.

"With Cloud Computing there are no hidden costs in terms of hardware, software, or 22 percent annual maintenance fees. You know exactly what you’re going to pay for, and people just love using Salesforce CRM," commented Lee Thompson, Sr. VP, corporate sales, Salesforce Asia Pacific.

Report this article Ask About This Article

More to Explore